GPT and COVID-19: According to these studies, it was estimated that 2–11% of patients with COVID-19 had pre-existing liver diseases and 16.1–53.1% of the infected patients had elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).6